Tiziana Life Sciences (TLSA) Expected to Post Quarterly Earnings on FridayMarket Beat·Sep 11 at 05:11 AMTLSA-4.18%
This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursdaybenzinga_article·Sep 3 at 12:10 PMNRSN-11.00%COP-0.04%
Global Crosscurrents and Macro Shifts Fragment US Thematic Equities in 2026Global Report·Sep 3 at 10:12 AMCRESY-0.16%ABEV+0.50%
Tiziana Life Sciences launches Phase 2a BANYAN trial of intranasal foralumab in ALSPUBT·Aug 24 at 11:00 AMTLSA-4.18%
Insider Buying: Tiziana Life Sciences (NASDAQ:TLSA) CEO Purchases 83,807 Shares of StockMarket Beat·Aug 6 at 03:07 PMTLSA-4.18%
Tiziana Life Sciences CEO Ivor Elrifi lifts stake to 4,472,261 shares after buying 667,000 at $1 apiecePUBT·Aug 4 at 11:00 AMTLSA-4.18%
Tiziana reports up to 34% drop in brain inflammation in third MSA patient on intranasal foralumab in Phase 2 trialPUBT·Jul 31 at 11:04 AMTLSA-4.18%
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal ForalumabUnusual Whales·Jul 31 at 11:03 AMTLSA-4.18%
Tiziana Life Sciences CEO Ivor Elrifi files initial beneficial ownership statementPUBT·Jul 23 at 08:21 PMTLSA-4.18%
